
Axitinib
CAS No. 319460-85-0
Axitinib( AG-013736 )
Catalog No. M14039 CAS No. 319460-85-0
Axitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 30 | In Stock |
![]() ![]() |
50MG | 41 | In Stock |
![]() ![]() |
100MG | 55 | In Stock |
![]() ![]() |
200MG | 69 | In Stock |
![]() ![]() |
500MG | 135 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameAxitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionAxitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
-
DescriptionAxitinib is an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3.
-
In Vitro——
-
In Vivo——
-
SynonymsAG-013736
-
PathwayAngiogenesis
-
TargetPDGFR
-
RecptorPDGFRβ| VEGFR1/FLT1| VEGFR2/Flk1| VEGFR2/KDR| VEGFR3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number319460-85-0
-
Formula Weight386.47
-
Molecular FormulaC22H18N4OS
-
Purity>98% (HPLC)
-
SolubilityDMSO: 35 mg/mL warmed (90.56 mM)
-
SMILESO=C(NC)C1=CC=CC=C1SC2=CC3=C(C=C2)C(/C=C/C4=NC=CC=C4)=NN3
-
Chemical Name(E)-N-methyl-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hu-Lowe DD, et al. Clin Y Res, 2008, 14(22), 7272-7283.
molnova catalog



related products
-
GF109203X
GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ, respectively.
-
PDGFRα kinase inhibi...
PDGFRα kinase inhibitor 1 is a highly selective inhibitor of type II PDGFRα kinase (PDGFRα and PDGFRβ) with IC50 values of 132 nM and 6115 nM, respectively.
-
CT52923
CT52923 is a selective, orally active antagonist of platelet-derived growth factor receptor (PDGFR), functioning as an ATP-competitive inhibitor.